Joy Wolfram

Last updated
Joy Wolfram
Born1989 (age 34–35)
Finland
Alma mater University of Helsinki (Bachelor's & Master's)
University of the Chinese Academy of Sciences (PhD)
Scientific career
Fields Nanomedicine
Nanotechnology
Nanoparticle drug delivery
Biotechnology
Medical diagnosis
Institutions Mayo Clinic
Houston Methodist Hospital
University of North Florida
University of Queensland

Joy Wolfram (born 1989) is a Finnish nanoscientist. [1] [2] She is known for her pioneering work in nanomedicine concerning the treatment of cancer, [3] cardiovascular diseases and other life-threatening illnesses. [4] [5] She is an Associate Professor at the University of Queensland, in the school of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology. [1] [2] She was the forefront of the Extracellular Vesicles and Nanomedicine laboratory at Mayo Clinic. [6] She is also an affiliate faculty member at Houston Methodist Hospital's Department of Nanomedecine. Wolfram sits as a scientific advisor and as a board member of several biotechnology companies around the world. [7]

Contents

Personal life

Wolfram was born and raised in Finland. Her father is Ben Wolfram and her mother is artist Maria Wolfram.

Wolfram's interest in science started at 11 years old after seeing the swab cultures of her dog's infection seeded in bacterial plates. She was fascinated that she asked the veterinarian if she may have culture supplies, and the veterinarian refused but later decided to give her in private. Wolfram then built her miniature microbiology laboratory. Her first experiment was swabbing shelves in their refrigerator. The bacterial plates were later covered with different shapes and various colors, and she thought it was cool even after it horrified her family as she announced that their fridge was crawling with bacteria.

In 2018, Wolfram's friend, Rebecca, succumbed to recurring cancer. The experience further motivated her on her cancer treatment research via nanotechnology. [3]

Education

In 2010, Wolfram graduated with a master's degree in Biology from the University of Helsinki. She was also a part-time researcher at the University's Institute of Biotechnology. In 2016, Wolfram earned a Ph.D. in Nanotechnology from the University of Chinese Academy of Sciences. [8]

Career and research

Wolfram was an Amgen Scholar and she participated in a research at Karolinska Institute in 2009 regarding a novel protein that increases the migration of cancer cells. The program solidified her desire to study translational cancer. [9]

She has been a visiting scholar at the Department of Molecular and Cellular Biology Research, Sunnybrook Health Sciences Centre, Toronto, Canada, in 2010, investigating antiangiogenic receptor tyrosine kinase inhibitors.

Wolfram began working as a research fellow for cancer and nanomedicine at the Houston Methodist Hospital in 2011. As she obtained her Ph.D. degree in 2016 she became a postdoctoral fellow.

Wolfram worked as an Associate Research Professor at the Wenzhou Institute of Biomaterials and Engineering from 2017–2019.

In 2017, she began holding affiliate faculty positions at the Houston Methodist's Department of Nanomedicine and at the University of North Florida's Department of Biology. In the same year she also became as an Assistant Professor of Medicine at Mayo Clinic, where she has been the director of the Nanomedicine and Extracellular Vesicles Laboratory until January 2022. [8] Her research programs are dedicated for the detection, diagnosis and treatment of various diseases. [5] Her research aims to produce nanomedicine with increased therapeutic properties to suppress side effects. [10] Wolfram had come up with strategies for modulating the immune system to allow accurate drug delivery to tumors, [11] particularly through the use of chloroquine [12] or through the body's own nanoparticles. In her TED talk Wolfram notes that there are over 10 clinically approved nanoparticles for treating cancer. [13]

Despite her young age, she has already authored over 60 publications on nanoscale strategies for cancer and other life-threatening diseases, received more than 30 awards and given many important conference talks around the world. As of March 2023, she has an h-index of 40. She was also named Finnish Expatriate of the Year in 2021.

Other activities

Wolfram is an advocate for increasing diversity in science, especially with underrepresented gender and racial minorities. [14] [15] She is also active in community outreach programs. Since 2016, she has been the representative of the Education and Outreach Unit of the National Cancer Institute's Center for Immunotherapeutic Transport Oncophysics at the Houston Methodist Research Institute. [16] [8]

Honors & awards

Related Research Articles

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials.

<span class="mw-page-title-main">Nanorobotics</span> Emerging technology field

Nanoid robotics, or for short, nanorobotics or nanobotics, is an emerging technology field creating machines or robots whose components are at or near the scale of a nanometer. More specifically, nanorobotics refers to the nanotechnology engineering discipline of designing and building nanorobots with devices ranging in size from 0.1 to 10 micrometres and constructed of nanoscale or molecular components. The terms nanobot, nanoid, nanite, nanomachine and nanomite have also been used to describe such devices currently under research and development.

<span class="mw-page-title-main">Nanobiotechnology</span> Intersection of nanotechnology and biology

Nanobiotechnology, bionanotechnology, and nanobiology are terms that refer to the intersection of nanotechnology and biology. Given that the subject is one that has only emerged very recently, bionanotechnology and nanobiotechnology serve as blanket terms for various related technologies.

The impact of nanotechnology extends from its medical, ethical, mental, legal and environmental applications, to fields such as engineering, biology, chemistry, computing, materials science, and communications.

Izon Science Limited is a nanotechnology company that develops and sells nano-scale particle analysis and isolation tools. Their main instruments are based on principles of size exclusion chromatography and tunable resistive pulse sensing. Izon’s size-exclusion chromatography columns and related solutions are also used by diagnostics companies focused on developing extracellular vesicle biomarkers.

Heart nanotechnology is the "Engineering of functional systems at the molecular scale".

The applications of nanotechnology, commonly incorporate industrial, medicinal, and energy uses. These include more durable construction materials, therapeutic drug delivery, and higher density hydrogen fuel cells that are environmentally friendly. Being that nanoparticles and nanodevices are highly versatile through modification of their physiochemical properties, they have found uses in nanoscale electronics, cancer treatments, vaccines, hydrogen fuel cells, and nanographene batteries.

<span class="mw-page-title-main">Paula T. Hammond</span> American chemical engineer (born 1963)

Paula Therese Hammond is a David H. Koch Professor in Engineering and the Head of the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT). She was the first woman and person of color appointed as head of the Chemical Engineering department. Her laboratory designs polymers and nanoparticles for drug delivery and energy-related applications including batteries and fuel cells.

<span class="mw-page-title-main">Tamara Minko</span> Pharmaceutical researcher

Tamara Minko is a distinguished professor and chair of the department of pharmaceutics at Rutgers University, Ernest Mario School of Pharmacy. She has an H-index of 43 since 2016 and over 17,800 citations of her work.

Hadiyah-Nicole Green is an American medical physicist, known for the development of a method using laser-activated nanoparticles as a potential cancer treatment. She is one of 66 black women to earn a Ph.D. in physics in the United States between 1973 and 2012, and is the second black woman and the fourth black person ever to earn a doctoral degree in physics from The University of Alabama at Birmingham.

Mauro Ferrari is a nanoscientist and leader in the field of nanomedicine. He served as special expert on nanotechnology for the National Cancer Institute (2003-2005) and was instrumental in establishing the Alliance for Nanotechnology in Cancer in 2004. On 1 January 2020, Ferrari was made president of the European Research Council (ERC). Following a vote of no confidence, on 27 March 2020, "all 19 active members of the ERC’s Scientific Council individually and unanimously requested that Mauro Ferrari resign from his position as ERC’s President", due to poor conduct in office, exploiting the position to further his own projects, and for consistently failing to represent the interests of the ERC. On 7 April 2020, Ferrari officially resigned, stating to the media that he was "extremely disappointed by the European response” to the pandemic and expressing frustration over opposition to his efforts to launch a scientific program to combat the virus.

<span class="mw-page-title-main">Ambika Bumb</span> American businesswoman and medical researcher

Ambika Bumb an American biomedical scientist and businessperson. Bumb is a nanomedicine specialist who uses nanotechnology for the detection and treatment of disease. Her discoveries using nanodiamonds while working as postdoctoral researcher at the National Cancer Institute and the National Heart, Lung, and Blood Institute led to the launch of the biotech Bikanta.

<span class="mw-page-title-main">Tessy María López Goerne</span> Mexican solid-state chemist

Tessy María López Goerne is a Mexican solid-state chemist, professor, researcher, academic, and popular science communicator. She has specialized in the fields of nanotechnology and nanomedicine, as well as being a pioneer in catalytic nanomedicine. She directs the Nanotechnology and Nanomedicine Laboratories at the Universidad Autónoma Metropolitana Xochimilco (UAM-X) plant and the National Institute of Neurology and Neurosurgery.

<span class="mw-page-title-main">Ijeoma Uchegbu</span> Nigerian-British pharmacist and Professor of Pharmacy

Ijeoma Uchegbu is a Nigerian-British Professor of Pharmacy at University College London where she held the position of Pro-Vice Provost for Africa and the Middle East. She is the Chief Scientific Officer of Nanomerics, a pharmaceutical nanotechnology company specialising in drug delivery solutions for poorly water-soluble drugs, nucleic acids and peptides. She is also a Governor of the Wellcome, a large biomedical research charity. Apart from her highly cited scientific research in Pharmaceutical Nanoscience, Uchegbu is also known for her work in science public engagement and equality and diversity in Science, Technology, Engineering and Mathematics (STEM). In December 2023, it was announced that she will become President of Wolfson College, Cambridge in October 2024.

Nanoinformatics is the application of informatics to nanotechnology. It is an interdisciplinary field that develops methods and software tools for understanding nanomaterials, their properties, and their interactions with biological entities, and using that information more efficiently. It differs from cheminformatics in that nanomaterials usually involve nonuniform collections of particles that have distributions of physical properties that must be specified. The nanoinformatics infrastructure includes ontologies for nanomaterials, file formats, and data repositories.

<span class="mw-page-title-main">Laurent Levy</span> French Scientist and Entrepreneur

Laurent Levy is a French physical chemist, inventor, and pioneer of nanotechnology and nanomedicine. He is the co-founder of the global biotechnology company Nanobiotix, and has served as chief executive officer (CEO) since its inception in March 2003. He also authored more than 35 international scientific publications and has applied for several patents.

<span class="mw-page-title-main">Elizabeth Nance</span> American chemical engineer

Elizabeth Nance is an American chemical engineer. She has held the Clare Boothe Luce Assistant Professorship at the University of Washington since September 2015. Her primary research interests are "disease-directed engineering, nanomedicine-based and nanometabolic-based platform development, systems thinking to assess and model therapeutic barriers in treating disease, and biological transport phenomena".

Helen M. Burt is a British-Canadian pharmaceutical scientist who is the Angiotech Professor of Drug Delivery at the University of British Columbia. She serves as Associate Vice President of Research and Innovation at UBC. Her research considers novel therapeutics based on nanotechnology, including drug delivery systems for the treatment of bladder cancer and coronary artery disease.

<span class="mw-page-title-main">Katja Keitaanniemi</span> Finnish business executive

Katja Keitaanniemi is the CEO of OP Corporate Bank, which is the most significant subsidiary of OP Financial Group. According to Corporate Finance Institute, OP Corporate Bank is among the top corporate banks in Finland. Keitaanniemi has been on the list of Finland's most powerful female executives by the business weekly Talouselämä in 2020, 2021, 2022 and 2023.

Moein Moghimi is a British professor and researcher in the fields of nanomedicine, drug delivery and biomaterials. He is currently the professor of Pharmaceutics and Nanomedicine at the School of Pharmacy and the Translational and Clinical Research Institute at Newcastle University. He is also an adjoint professor at the Skaggs School of Pharmacy, University of Colorado Denver.

References

  1. 1 2 "New appointments to build teaching and research capabilities". chemeng.uq.edu.au. 16 March 2022. Retrieved 25 March 2022.
  2. 1 2 "Advice to my 16 year old self - featuring Associate Professor Joy Wolfram". aibn.uq.edu.au. Retrieved 25 March 2022.
  3. 1 2 Mirchevski, Bruno (HE) (8 November 2019). "An Interview with Joy Wolfram, Forbes (US & Canada 2019) Healthcare". Medium. A Medium Corporation. Retrieved 22 September 2020.
  4. ↑ Laakso, Leena. "Suomi tarvitsee lisää Joy Wolframeja". Tärkeimmät talousuutiset | Kauppalehti (in Finnish). Alma Media Corporation. Retrieved 22 September 2020.
  5. 1 2 "Nanomedicine and Extracellular Vesicles Laboratory - Overview". Mayo Clinic. Mayo Foundation for Medical Education and Research. Retrieved 22 September 2020.
  6. ↑ Will, Robinson. "TEDxJacksonville 2018: The promise of nanomedicine". www.bizjournals.com. American City Business Journals. Retrieved 22 September 2020.
  7. ↑ Wolfram, Joy. "Joy Wolfram | Speaker | TED". www.ted.com. TED Conferences, LLC. Retrieved 22 September 2020.
  8. 1 2 3 4 "Joy Wolfram (0000-0003-0579-9897)". orcid.org. Retrieved 22 September 2020.
  9. 1 2 "Big Impact in Bio: Developing Nanomedicine and Mentoring Young Scientists the World-Over". Amgen Scholars. Amgen Foundation, Inc. Retrieved 22 September 2020.
  10. ↑ Tiner, Sara. "Nanoparticles From Fat May be Useful in Treating Inflammatory DiseasesDiscovery's Edge" . Retrieved 22 September 2020.
  11. ↑ "Age-old malaria treatment found to improve nanoparticle delivery to tumors: Nanomedicine researchers find new use for 70-year-old drug". ScienceDaily. Science Daily, LLC. 21 September 2020. Retrieved 22 September 2020.
  12. ↑ "70-year-old malaria drug found to improve treatment of tumors". Nano Magazine - Latest Nanotechnology News. Nano Media Group. Retrieved 22 September 2020.
  13. ↑ Wolfram, Joy (October 2018). "How nanoparticles could change the way we treat cancer". TED Conferences, LLC. Retrieved 22 September 2020.
  14. ↑ Elizabeth, Zimmermann. "Why mentor? One researcher's story" . Retrieved 22 September 2020.
  15. ↑ "UNF - Media Relations - UNF holds 6th Annual Women Leaders in STEM Conference". www.unf.edu. Retrieved 22 September 2020.
  16. ↑ "Seminari VHIR - Dra. Joy-Emelie Wolfram "Diagnostic and therapeutic biogenic nanoparticles"". Vall d'Hebron Barcelona Hospital Campus. 19 August 2020. Retrieved 22 September 2020.
  17. ↑ "SUOMEN NUORKAUPPAKAMARIT RY: TOYP Suomi –kilpailun voittajat on valittu". Tärkeimmät talousuutiset | Kauppalehti (in Finnish). Alma Media Corporation. 4 October 2019. Retrieved 22 September 2020.
  18. ↑ "Joy Wolfram". Forbes. Retrieved 22 September 2020.
  19. ↑ "2020 Shortlist | Nature Research Awards for Inspiring and Innovating Science". www.nature.com. Springer Nature Limited. Retrieved 22 September 2020.
  20. ↑ "Rising Stars in Cancer Research". offers.the-scientist.com. LabX Media Group. Retrieved 22 September 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.